Acorda Therapeutics Inc
ACOR
Market Cap$0
Close$
$7.00
959.8% upside
Current Fair Value
959.8% upsideUndervalued by 959.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $156.16 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-203.59 |
| Beta | 0.0 |
| Outstanding Shares | 1,242,098 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | -0.0 |
| Price to Sales | 0.01 |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 1.33 |
| Enterprise Value to EBIT | -6.71 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.19 |
| Debt to Equity | -1.18 |
Revenue Sources
No data
ESG Score
No data
About Acorda Therapeutics Inc
CEO: Ron Cohen